Inari Medical (NARI)
(Delayed Data from NSDQ)
$41.80 USD
+1.17 (2.88%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $41.73 -0.07 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
NARI 41.80 +1.17(2.88%)
Will NARI be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NARI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NARI
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall
NARI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inari Medical (NARI) Q2 Earnings Miss, Revenues Increase Y/Y
Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates
What's in Store for DENTSPLY SIRONA (XRAY) in Q2 Earnings?
Other News for NARI
ClearBridge Small Cap Growth Strategy Q3 2024 Commentary
Breaking Down Inari Medical: 9 Analysts Share Their Views
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN) and Inari Medical (NARI)
Inari Medical Inc (NARI) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges
Inari Medical Inc (NARI) Shares Up 3.22% on Oct 2